This federal contract IDV award to Glaxosmithkline, LLC from the Department of Veterans Affairs (VA) National Acquisition Center procures influenza vaccines for use by the VA, Bureau of Prisons (BOP), Indian Health Service (IHS), and Captain James A. Lovell Federal Health Care Center. The contract has a total estimated annual usage of 306,829 vaccine doses across various product types including 10-dose vials, pre-filled pediatric syringes, and pre-filled syringes for adults 36 months and older, including those specifically designed for the 65+ population.
The contract is not set aside for any special business category. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, will deliver the vaccines across the U.S., Philippines, and Puerto Rico under a firm fixed price arrangement with a period of performance from August 2024 through October 2024. This award supports federal vaccination and disease prevention efforts for veterans, inmates, Native Americans, and active duty personnel and their families. Multiple delivery order contracts issued against this IDV provide additional details on product types, quantities, and pricing for specific government facilities.
Generated 12/27/24, 9:05 AM